LesionQuant

by CorTechs Labs  · Based in United States →Empowering precision and clarity in patient care.
Neurology Radiology

Overview

LesionQuant, developed by CorTechs Labs, is an artificial intelligence (AI) tool designed for the quantitative assessment of magnetic resonance imaging (MRI) scans, specifically in the context of multiple sclerosis (MS). It is intended for use by neurologists, neuroradiologists, and other clinicians involved in the diagnosis and monitoring of MS patients.

The tool integrates into clinical workflow by providing automated analysis of MRI data. It focuses on:

  • Lesion Volume Measurement: Quantifying the total volume of lesions.
  • Lesion Count: Identifying and counting individual lesions.
  • Lesion Distribution: Analyzing the spatial arrangement of lesions within the brain.
  • Brain Atrophy: Assessing changes in brain volume, which can be indicative of disease progression.

LesionQuant aims to supplement visual inspection of MRI scans by providing objective, quantitative measurements. This can potentially offer a more detailed and consistent evaluation of disease progression over time, aiding in treatment planning and patient management for individuals with multiple sclerosis.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated segmentation and volumetric analysis of brain structures
  • Quantification of lesion volume, count, and distribution
  • Comparison of current brain volumes and lesions to prior studies
  • Identification and quantification of new, active, and resolving lesions
  • Color-coded lesion visualization and lesion change visualization
  • Brain atrophy assessment
  • Normative reference data for comparison of patient brain volumes to healthy cohorts
  • Customizable lesion detection settings and minimum lesion size threshold
  • Compatibility with various MRI scanners (Siemens, GE, Philips, Toshiba, Hitachi)
  • Comprehensive FLAIR lesion and brain structure volumetric reports

Use Cases

  • Diagnosis and monitoring of multiple sclerosis
  • Assessment of neurodegenerative disorders like Alzheimer's and dementia
  • Evaluation of brain trauma
  • Monitoring epilepsy
  • Clinical treatment planning and monitoring of disease progression
  • Quantitative analysis of brain lesions and atrophy in a clinical setting

What Physicians Need to Know

Brain MRI/CT Analysis
LesionQuant automatically segments and quantifies brain structures and lesions from 3D T1 and FLAIR MRI images. It provides total number and volume of lesions, lesion burden calculation, and identifies new and enlarging lesions. The software also quantifies up to 8 relevant brain structures and compares them to age- and gender-matched normative percentiles. It offers color-coded lesion visualization and lesion change visualization. The tool is FDA-cleared and CE marked.
Neurodegenerative Disease Screening
LesionQuant aids in assessing various neurological conditions, including Alzheimer's disease, epilepsy, multiple sclerosis, brain trauma, and brain development. It is particularly useful for patients with multiple sclerosis, providing brain structure data and quantifying the number, size, and location of lesions, comparing them to prior studies. The software helps identify and assess neurodegeneration in its earliest stages.
Physician Tip

LesionQuant offers customizable lesion detection settings, allowing physicians to configure minimum lesion size (1 to 64 mmu00b3) and lesion separation thresholds (1 to 5 mm) to suit individual diagnostic needs and scanner protocols. Consistent scanner protocol settings and lesion settings are crucial for accurate longitudinal tracking of lesion changes. The software provides color-coded overlays to visualize lesion changes, distinguishing between new, active (enlarging/increasing intensity), stable, and resolving lesions. This can help monitor disease progression and patient response to treatment without the need for gadolinium contrast in some cases.

LesionQuant is designed for easy integration into existing PACS systems. It processes 3D T1 structural scans and 2D/3D FLAIR MR images. The system requires both the 3D T1 and FLAIR scans for a patient to have matching patient IDs and be acquired in the same session for processing to commence. Results, including color-coded FLAIR overlays, can be reviewed directly on PACS or DICOM viewers. Processing time for analysis is typically over 10 minutes.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Unknown Contact CorTechs Labs for pricing information.
DeploymentCloud-based system
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated

LesionQuant is a module of NeuroQuant, which received FDA 510(k) clearance for quantitative brain image analysis. It assists physicians in clinical evaluation, treatment planning, and monitoring disease progression by combining T2 FLAIR with 3D T1 scans for quantitative lesion analysis.

Integrations
EHR Not specified
Specialties Neurology, Radiology

What the Web Says

LesionQuant is an FDA-cleared and CE-marked AI-powered software module that assists physicians in quantifying and tracking brain lesions and atrophy, particularly useful in conditions like Multiple Sclerosis (MS) and dementia. It provides automated FLAIR lesion and brain volume measurements, compares them to normative data, and visualizes changes over time. The software aims to offer more accurate and reproducible assessments compared to traditional visual inspection or manual segmentation, which can be subjective.

Overall: Positive

Strengths

  • Provides fast, accurate, and reproducible automated FLAIR lesion and brain volume measurements.
  • Helps in proficiently assessing disease activity in MS by identifying new and enlarging T2 FLAIR lesions.
  • Offers visualization of lesion changes and brain structure changes when prior studies are available.
  • Can aid in the assessment of patients with dementia by determining atrophy in specific brain regions, especially in early stages.
  • Reduces inter- and intra-rater variability often associated with manual lesion evaluation.
  • Allows for user-configured lesion segmentation parameters, such as minimum lesion size and separation, for personalized analysis.

Limitations

  • Requires both 3D T1 and 2D/3D FLAIR MRI series for processing, and patient IDs must match with both series acquired in the same session.
  • Some users on Reddit express general skepticism about AI tools for MRI analysis, citing concerns about accuracy in distinguishing normal anatomical differences from lesions and potential privacy issues with web uploads.
  • One Reddit user reported that an AI analysis (NeuroQuant, which LesionQuant is a module of) showed lesions that their neurologist hadn't mentioned, leading to confusion.
  • Subtle differences in structural volumes might occur when compared to T1-only segmentations due to the additional T2 FLAIR data used by LesionQuant.
  • It is critical that scanner protocol settings and lesion settings remain consistent between time points for accurate detection of subtle lesion changes.

Based on reviews from: Cortechs.ai, Neurology, InventUM, PubMed, medRxiv, Reddit

Last updated: 2026-09-11

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate LesionQuant

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Cortechs.ai
Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuantu00ae Technologies
Cortechs.ai announced a partnership with Siemens Healthineers to integrate and distribute its FDA-cleared NeuroQuantu00ae Lesion Surveillance through the Siemens Healthineers Digital Marketplace, aiming to accelerate global adoption of quantitative brain imaging.
2026-03
InventUM (University of Miami Miller School of Medicine)
New AI Technology Can Help Assess Brain Lesions and Atrophy - InventUM
Physicians at the University of Miami Miller School of Medicine are using FDA-approved NeuroQuant and LesionQuant AI software from CorTechs Labs to make more precise brain measurements for patients with neurological disorders like Alzheimer's, dementia, multiple sclerosis, brain trauma, and epilepsy.
22020-07
Cortechs.ai
Cortechs.ai and HealthLytix announce merger
Cortechs.ai merged with HealthLytix, a healthcare technology company, to broaden its focus to include quantitative analysis software for cancer screening and early detection, in addition to its neuroimaging solutions like LesionQuant.
2020-06
Frontiers in Neurology (via PMC)
LesionQuant for Assessment of MRI in Multiple Sclerosisu2014A Promising Supplement to the Visual Scan Inspection
A study published in Frontiers in Neurology explored the use of LesionQuant software for evaluating cerebral MS lesions and brain atrophy, suggesting it is a promising supplement to visual neuro-radiological evaluations.
2020-12
Business Wire
CorTechs Labs Presents Findings on the Creation of Machine Learning Models to Aid Early, Accurate Diagnosis of Multiple Sclerosis (MS) at ACTRIMS 2020
CorTechs Labs exhibited LesionQuant's capabilities at ACTRIMS 2020, showcasing its ability to segment and quantify new, active, and resolving lesions, as well as gray and white matter.
2020-02
Industry News
CorTechs Labs presents quantitative analysis software for neuro imaging
CorTechs Labs highlighted its quantitative analysis software portfolio, including NeuroQuantu00ae, LesionQuantu2122, and PETQuantu2122, which aid in diagnosing and treating neurodegenerative diseases like Alzheimer's, epilepsy, multiple sclerosis, and brain trauma.
2019-12
Cortechs.ai
LesionQuant V3.0 Expands and Personalizes Lesion Quantification
CorTechs Labs released LesionQuant V3.0, expanding its capabilities for assessing demyelinating diseases with improved lesion identification, monitoring of new, active, and resolving lesions, and personalized threshold settings.
2019-09
DOTmed
NeuroQuant receives clearance in Brazil for clinical use
NeuroQuant, including its LesionQuant module, received regulatory clearance in Brazil for clinical use, expanding CorTechs Labs' global reach for quantitative neuroimaging solutions.
2019-10

Videos

Product demos, reviews, and walkthroughs for LesionQuant.

Loading videos...

View all on YouTube

Frequently Asked Questions

LesionQuant is an AI-powered software designed to quantify and track brain lesions, particularly in conditions like multiple sclerosis, by analyzing MRI scans. It integrates into a neurological practice by providing automated, objective measurements that can assist physicians in monitoring disease progression and treatment effectiveness, potentially streamlining the assessment process.
LesionQuant, as a medical device software, is designed to comply with stringent data privacy regulations such as HIPAA and GDPR. It typically achieves this through robust data anonymization and de-identification protocols, secure data transmission, and access controls, ensuring patient confidentiality throughout the imaging and analysis workflow.
While effective for quantifying certain types of brain lesions, LesionQuant has clinical limitations. It may not be optimized for all lesion types, such as those in very early stages, or for conditions where lesion boundaries are indistinct or highly variable. Physicians should understand its validated use cases and interpret results in conjunction with comprehensive clinical evaluation.
LesionQuant offers advantages over traditional manual methods by providing objective, reproducible, and time-efficient lesion quantification. Compared to other AI tools, its specific algorithms and validation may differ, potentially offering superior performance for certain lesion types or imaging sequences. Physicians should evaluate its performance metrics and clinical validation against alternatives for their specific needs.
The pricing model for LesionQuant typically involves a subscription or per-study fee, varying based on the volume of scans and desired features. It is generally designed to be compatible with various healthcare IT infrastructures, often integrating with existing PACS (Picture Archiving and Communication Systems) and EMR (Electronic Medical Record) systems through standard protocols, though specific integration requirements should be confirmed.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.
Stealth AXiS Cranial clinical application
Medtronic
Neurology AI
Stealth AXiS Cranial is an AI-enabled surgical navigation application by Medtronic Navigation, Inc. designed to enhance precision and visualization during cranial procedures.

See all Neurology AI tools →

More from CorTechs Labs

NeuroQuant
CorTechs Labs
Neurology AI
NeuroQuant by CorTechs Labs is an FDA-cleared, AI-powered software for automated brain MRI segmentation and volumetric analysis, aiding in the diagnosis and monitoring of neurodegenerative diseases, brain trauma, and tumors.
OnQ Neuro
CorTechs Labs
Neurology AI
OnQ Neuro by CorTechs Labs is an FDA-cleared, AI-powered software for automated segmentation and volumetric quantification of brain tumors on MRI, supporting clinical analysis and interpretation.

View company profile →

Suggest an Edit → | Last Verified: 2026-09-09 | First Added: 2026-09-09
AI Tool Finder
AI-powered search. Results may not be comprehensive.